Skip to main content
. 2018 Dec 31;71(6):356–363.

Table 2.

Baseline Characteristics

Characteristic Study Group; No. (%) of Patients* p Value

Pre-implementation (n = 70) Post-implementation (n = 67)
Age (years) (mean ± SD) 88.1 ± 4.3 88.4 ± 5.1 0.75

Sex, male 32 (46) 30 (45) 0.91§

RRAS (mean ± SD) 11.7 ± 1.4 11.5 ± 1.4 0.52

No. of comorbidities (mean ± SD) 6.5 ± 2.7 6.5 ± 3.0 0.76

Medications on admission
 No. of medications on admission (mean ± SD) 8.0 ± 3.5 8.3 ± 3.9 0.61
 No. of Beers list medications on admission (mean ± SD) 0.9 ± 1.0 1.0 ± 1.0 0.56
 No. (%) of patients taking > 5 medications 53 (76) 48 (72) 0.59§

Living arrangements before admission
 Home with family 26 (37) 21 (31) 0.47§
 Home alone 10 (14) 17 (25) 0.10§
 Care facility 17 (24) 10 (15) 0.17§
 Home care 15 (21) 5 (7) 0.20§
 Unknown 2 (3) 14 (21)

Medication compliance aid
 Blister pack 13 (19) 33 (49) < 0.001§
 Vials 7 (10) 14 (21) 0.08§
 Dosette 4 (6) 5 (7) 0.68§
 Unknown 46 (66) 15 (22)

Independence with medications
 Needs assistance 27 (39) 30 (45) 0.46§
 Independent 19 (27) 27 (40) 0.10§
 Unknown 24 (34) 10 (15)

RRAS = Readmission Risk Assessment Score, SD = standard deviation.

*

Except where indicated otherwise.

By independent-samples t test.

§

By χ2 test.